A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132

Part of paid clinical trials in Farmington, Connecticut.

Sponsor
Bristol-Myers Squibb
Study ID
NCT06875960
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

  • Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)
  • Systemic Lupus Erythematosus (SLE)

Eligibility Criteria

Sex
ALL
Age
18 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

  • BMS-986165 — DRUG
    Specified dose on specified days

Study Details

The purpose of this study is to allow the continued administration of Deucravacitinib in participants with Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) who have completed study IM011074 or Study IM011132

Key Dates

Start date
Feb 24, 2026
Status verified
Mar 2026
Primary completion
Dec 1, 2026
Completion
Dec 1, 2026

Study Design

Enrollment
35 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Administration of BMS-986165

Primary Outcome Measure

Number of participants treated with BMS-986165 [ Time Frame: Up to 2 years ]

Central Contacts

  • BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
    855-907-3286
    [email protected]
  • First line of the email MUST contain NCT # and Site #.

Locations (4)

FacilityCityStateZIPSite coordinators
Local Institution - 0001FarmingtonConnecticut06030-
New York University School Of MedicineNew YorkNew York10155
Amit Saxena, Site 0002
646-501-7387
Oklahoma Medical Research FoundationOklahoma CityOklahoma73104
Cristina Arriens, Site 0004
405-271-7805
Local Institution - 0003JacksonTennessee38305-

Find similar trials in Farmington, CT

By research site
Local Institution - 0001· Farmington, CTNew York University School Of Medicine· New York, NYOklahoma Medical Research Foundation· Oklahoma City, OKLocal Institution - 0003· Jackson, TN

Related Studies